Jaguar Health Inc (FRA:1JA)
€ 7.56 0 (0%) Market Cap: 11.62 Mil Enterprise Value: 31.50 Mil PE Ratio: 0 PB Ratio: 0.80 GF Score: 23/100

Ladenburg Thalmann to Host Virtual Discussion with Jaguar Health Inc Transcript

Jun 22, 2023 / 05:00PM GMT
Release Date Price: €25.08 (+1.95%)
Jeffrey Scott Cohen
Ladenburg Thalmann & Co. Inc., Research Division - MD of Equity Research

Thank you for joining us. I am Jeff Cohen, I joined with my colleague Destiny Hance at Ladenburg Thalmann. Today, we're happy to have Lisa Conte with us. Lisa is CEO, President and Director of (inaudible) of Jaguar Health. Lisa, thanks for the time. We really appreciate it. We're not going to dive as macro into the company, Jaguar, but today is really focused around CTD specifically the Phase 3 trial and patient experience.

So Lisa I'm going to turn it over to you.

Lisa A. Conte
Jaguar Health, Inc. - Founder, CEO, President & Director

Thanks. You just want to unmute, but you already have turned it over to me. So we're good. And thank you. Thank you for the time and the opportunity to fill people in and we're so excited about what we feel will be absolutely transformative for patients and for value recognition in this company right now in this really tough, tough biotech markets.

We have completed enrollment in the study we call the OnTarget

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot